Cell Marker Predictors in Barrett's Esophagus

Barrett's Esophagus Without Dysplasia Clinical Trial

Official title:

Cell Marker Predictors in Barrett's Esophagus

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT03316053
• Other study ID #: 1708-43
• Status: Active, not recruiting
• Start date: November 15, 2017
• Est. completion date: December 1, 2025

Study information

• Verified date: February 2024
• Source: The Guthrie Clinic
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to analyze biopsied tissue samples for changes in cells and genes involved in Barrett's Esophagus.

Description:

Patients with a history of Barrett's esophagus who are scheduled for a routine endoscopy will have an additional biopsy taken for genetic testing.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 25
• Est. completion date: December 1, 2025
• Est. primary completion date: December 1, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• History of Barrett's esophagus; scheduled for routine upper endoscopy

Exclusion Criteria:

• Under 18 years of age
• Unable to consent on own behalf

Related Conditions & MeSH terms

• Barrett Esophagus
• Barrett's Esophagus Without Dysplasia

Intervention

Other:
• Tissue sample for genetic testing
Tissue sample to be obtained during routine endoscopy

Locations

Country	Name	City	State
United States	The Guthrie Clinic	Sayre	Pennsylvania

Sponsors (1)

Lead Sponsor	Collaborator
The Guthrie Clinic

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Cell Markers	Identify genes involved in Barrett's Esophagus	through study completion, an average of 1 year